PubMed HealthSearch

Biomedical subjects

D P Sendrowski

Publications and source records attributed to D P Sendrowski.

3 recordsLinked to original sources

An investigation of sympathetic hypersensitivity in chronic fatigue syndrome.

BACKGROUND: There are many theories, but the etiology of chronic fatigue syndrome (CFS) remains unknown. Diagnosticians have set guidelines to try to classify the condition, but its clinical definition is one of exclusion rather than defined by specific clinical testing. The primary goal of this investigation was to find a diagnostic key to define CFS. CFS patients and those diagnosed with the sympathetic hypersensitivity condition called fibromyalgia syndrome (FMS) exhibit identical brain single photon emission computerized tomography (SPECT) images. Therefore, this investigation was initiated to see if CFS patients also had denervation hypersensitivity of the sympathetic system. METHODS: A standardized supersensitivity test was performed using an ocular instillation of two drops of 1.0% phenylephrine. Sixty-two subjects (29 CFS patients and 33 normals) participated in the study. Measurements of pupil size were recorded by pupil gauge and flash photography. A pupillary dilation of greater than 2.5 mm would suggest a sympathetic denervation hypersensitivity. RESULTS: For all participants, a small, but statistically significant increase in pupil size was found (mean of 0.788 mm in normals and 0.931 mm in CFS patients). The change in pupil size in the CFS patients and controls showed substantial overlap and was not statistically significant (t = 0.83, p = 0.42, dF = 60). CONCLUSION: In conclusion, the results suggest that a denervation hypersensitivity of the pupil does not occur in CFS patients. The use of 1.0% topical phenylephrine had no diagnostic value in detecting CSF patients vs. normals.

Administration, Topical

Hyperthyroidism.

Hyperthyroidism is a condition in which the thyroid gland produces a greater than normal amount of hormone. The cause of this overproduction may be a direct result of many systemic disorders. If hyperthyroidism is associated with diffuse goiter, exophthalmos, or pretibial myxedema, it is commonly known as Graves' disease. The clinician is faced with a multifaceted disorder that has a predilection for the orbit. This orbitopathy places the patient at risk for visual loss. The diagnostician is better equipped to treat and manage visual anomalies if the pathophysiology of the systemic disease is understood. Such insight promotes a better co-management environment between optometrist and internist or endocrinologist. This chapter provides the reader with basic clinical guidelines to the disease process. It also offers a stepwise approach for diagnosing and treating the ocular changes that may be encountered.

Graves Disease

Unilateral pigmented mobile vitreous cyst.

A patient presented with a pigmented mobile vitreous cyst in the right eye. The cyst was 6-7 mm in diameter, and was free-floating in the inferior half of the vitreous with no apparent attachments. No other ocular pathology was present in either eye. The patient became symptomatic only when the cyst obscured the visual axis. The literature was reviewed and will be discussed in this report.

Adult